LOAMU
CTIC

Lombard Odier Asset Management (USA)’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Lombard Odier Asset Management (USA)’s Portfolio CTIC Stock Details CTIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-135,746
Closed -$1.67M – 213
2015
Q4 		$1.67M Buy
135,746
+5,432
+4% +$72.5K 0.17% 123
2015
Q3 		$1.9M Sell
130,314
-146,520
-53% -$2.53M 0.18% 143
2015
Q2 		$5.4M Buy
+276,834
New +$5.34M 0.46% 89
2015
Q1 		– Sell
-50,144
Closed -$1.18M – 271
2014
Q4 		$1.18M Buy
+50,144
New +$1.16M 0.11% 155

Other funds holding CTIC

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $114M AUM 77.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return